or Try an Advanced Search...

    Technical Analysis for AMLX - Amylyx Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    D 1.88 -1.05% -0.02
    AMLX closed down 1.05 percent on Monday, July 1, 2024, on approximately normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical AMLX trend table...
    Date Alert Name Type % Chg
    Upper Bollinger Band Walk Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Gapped Down Weakness 0.00%
    Shooting Star Candlestick Bearish -1.05%
    Lizard Bearish Bearish Day Trade Setup -1.05%
    Volume Surge Other -1.05%
    Upper Bollinger Band Walk Strength -1.05%
    Upper Bollinger Band Touch Strength -1.05%
    Expansion Pivot Buy Setup Bullish Swing Setup -2.59%
    Pocket Pivot Bullish Swing Setup -2.59%
    Older End-of-Day Signals for AMLX ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 5 hours ago
    60 Minute Opening Range Breakdown about 7 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    Rose Above Upper Bollinger Band about 9 hours ago
    Up 2% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AMLX Chart by TradingView
    Basic chart:

    Profile

    Amylyx Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada. The company is developing AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid for the treatment of ALS and other neurodegenerative diseases. It is also developing products for Wolfram syndrome and Alzheimer's diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Pharmaceutical Alzheimer's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Nervous System Apoptosis Neurodegenerative Disease

    Is AMLX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 Amylyx ventures into metabolic diseases market with $35.1m deal
    Jun 25 Amylyx Pharmaceuticals: Potential To Redeem Itself With Data Readouts And Possible GLP-1 Acquisition
    Jun 22 Amylyx inks deal to buy Eiger’s GLP-1 targeting drug
    Jun 4 Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
    May 10 Amylyx Pharmaceuticals Reports Q1 2024 Financial Results
    May 10 Breaking Down Amylyx Pharma: 9 Analysts Share Their Views
    May 10 Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript
    May 9 Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2024 Earnings Call Transcript
    May 9 Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates
    May 9 Amylyx Pharmaceuticals GAAP EPS of -$1.75 misses by $1.76, revenue of $88.64M misses by $9.71M
    See more AMLX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 25.48
    52 Week Low 1.575
    Average Volume 1,796,038
    200-Day Moving Average 10.56
    50-Day Moving Average 1.81
    20-Day Moving Average 1.76
    10-Day Moving Average 1.79
    Average True Range 0.12
    RSI (14) 53.05
    ADX 29.57
    +DI 26.83
    -DI 15.14
    Chandelier Exit (Long, 3 ATRs) 1.75
    Chandelier Exit (Short, 3 ATRs) 1.92
    Upper Bollinger Bands 1.93
    Lower Bollinger Band 1.58
    Percent B (%b) 0.85
    BandWidth 20.02
    MACD Line -0.02
    MACD Signal Line -0.07
    MACD Histogram 0.05
    Fundamentals Value
    Market Cap 126.93 Million
    Num Shares 67.5 Million
    EPS 0.01
    Price-to-Earnings (P/E) Ratio 188.00
    Price-to-Sales 3.73
    Price-to-Book 2.49
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.05
    Resistance 3 (R3) 2.05 2.00 2.02
    Resistance 2 (R2) 2.00 1.96 2.00 2.01
    Resistance 1 (R1) 1.94 1.93 1.97 1.94 2.00
    Pivot Point 1.89 1.89 1.91 1.89 1.89
    Support 1 (S1) 1.83 1.85 1.86 1.83 1.76
    Support 2 (S2) 1.78 1.82 1.78 1.75
    Support 3 (S3) 1.72 1.78 1.74
    Support 4 (S4) 1.72